7 picks for Conn's syndrome sleep: resistant nocturnal hypertension support, hypokalemia muscle cramp pressure relief, nocturia-friendly motion isolation, metabolic alkalosis sleep fragmentation cooling, and BP-headache head elevation -- distinct from essential hypertension recommendations.
Essential hypertension is idiopathic high blood pressure typically responsive to 1-2 medications, with normal nocturnal BP dipping and no associated electrolyte abnormalities -- standard supportive mattresses suffice. Secondary hyperaldosteronism results from elevated renin (renal artery stenosis, heart failure, cirrhosis) and is treated by addressing the underlying cause; sleep priorities follow the primary disease. Primary aldosteronism (Conn's syndrome) is autonomous aldosterone secretion with suppressed renin -- the ARR is elevated. It uniquely combines four sleep-disrupting features: (1) non-dipping resistant hypertension requiring head-of-bed elevation, (2) hypokalemia driving nocturnal muscle cramps requiring pressure-relief layers, (3) frequent nocturia (3-5 episodes) requiring strong motion isolation to spare partners, and (4) metabolic alkalosis contributing to restless sleep requiring cooling, supportive surfaces. A mattress chosen for "high blood pressure" alone will underserve Conn's syndrome patients on every dimension except the first.
Ranked for adjustable-base BP elevation, hypokalemic cramp pressure relief, nocturia motion isolation, and MRA-therapy comfort.
The Saatva Solaire is the single best mattress for primary aldosteronism because it addresses all four Conn's syndrome sleep mechanisms simultaneously. The built-in head elevation (no separate base required) delivers the precise 10-15 degree angle that modestly reduces nocturnal blood pressure in non-dipping patients -- critical for the 50-70% of Conn's patients whose BP fails to fall overnight. The foot elevation reduces peripheral fluid pooling during the day, decreasing the volume mobilized at night and modestly lowering nocturia frequency. The dual-zone air chambers allow each partner to dial their own firmness: the Conn's patient can choose a medium-firm setting that relieves hypokalemic calf and foot cramps without bottoming out, while a partner chooses their preferred feel. For patients on spironolactone who develop gynecomastia tenderness, the adjustable firmness can be softened on the chest side. The organic cotton cover and chemical-free wool fire barrier matter for patients on long-term MRA therapy who are often on multiple medications and sensitive to additional chemical exposure. Edge support is sufficient for the 3-5 nightly nocturia transitions to and from the bed edge -- important because orthostatic hypotension is a real risk when MRAs are titrated.
Hypokalemia in Conn's syndrome produces a specific nocturnal symptom pattern: calf cramps, foot cramps, generalized muscle weakness, and crawling paresthesias that wake patients repeatedly. The Tempur-Pedic ProAdapt's slow-response Tempur material conforms to the body more completely than any other comfort layer, distributing weight across the largest possible contact area and eliminating the pressure points that trigger nocturnal cramp episodes. For patients whose hypokalemia is being corrected with oral potassium supplementation or after initiation of MRA therapy, cramps gradually resolve -- but during the days-to-weeks transition, the ProAdapt minimizes their frequency. The mattress is fully adjustable-base compatible for the 10-15 degree head elevation that helps the non-dipping nocturnal BP pattern. Motion isolation is excellent -- important because the same hypokalemia that causes cramps also causes restless leg-like movements that would otherwise disturb a partner. The medium firmness suits the majority of side and back sleepers, which is important because side sleeping helps reduce nocturia frequency by promoting renal venous return. Heat retention has been improved in current ProAdapt models with the cooling cover, addressing the metabolic-alkalosis-related restlessness common in Conn's patients.
Nocturia is the single most partner-disruptive symptom of primary aldosteronism. Aldosterone-driven polyuria typically produces 3-5 nighttime bathroom trips -- each entry and exit from the bed transfers motion across the mattress and wakes the unaffected partner. The Helix Midnight Luxe's individually wrapped coil system delivers hotel-grade motion isolation: a partner getting up and returning to bed three to five times per night does not transmit detectable movement to the other side. The Tencel cover wicks moisture and stays cool, addressing the night sweats and restlessness that some Conn's patients experience with metabolic alkalosis or as a side effect of MRA therapy. The reinforced edge support is genuinely important here -- patients with frequent nocturia need a stable bed edge to sit on for the 15-30 seconds recommended before standing (orthostatic hypotension protection, especially during MRA titration). The mattress is fully adjustable-base compatible for head-of-bed elevation to manage the non-dipping nocturnal BP pattern. Side-sleeper pressure relief at the shoulder and hip is also valuable for patients on spironolactone who develop gynecomastia tenderness and can no longer comfortably sleep prone.
Early-morning headache is one of the most reliable symptoms of poorly controlled primary aldosteronism -- driven by sustained nocturnal hypertension in a non-dipping pattern. Head-of-bed elevation of 10-15 degrees on an adjustable base produces a modest but real reduction in nocturnal BP and a corresponding reduction in early-morning headache severity. The Saatva Classic is the most adjustable-base-friendly traditional hybrid on the market: the dual-coil construction flexes smoothly at the head-elevation bend point without creating pressure ridges or fold creases that disturb sleep. The medium-firm option supports the back and lumbar zones during elevation, preventing the lower-back strain that occurs when the spine is unsupported at the elevation hinge. The organic cotton cover and chemical-free wool fire barrier reduce total chemical exposure for patients on long-term MRA therapy and other antihypertensives -- a meaningful consideration for medication-heavy regimens. Edge support is excellent for the safe transition from lying to seated for nocturia trips. The 365-night trial provides ample time to determine whether elevation actually reduces morning headache frequency, which is the practical test of whether this approach is working for any individual patient.
Metabolic alkalosis in Conn's syndrome -- caused by hydrogen ion loss alongside potassium wasting -- contributes to restless sleep, night sweats, and a subtle hyperventilation pattern that fragments sleep architecture. The Purple Restore Hybrid's hyper-elastic polymer grid is the most thermally neutral comfort layer on the market: airflow passes directly through the grid structure, so body heat does not accumulate at the sleep surface. For Conn's patients experiencing night sweats or temperature dysregulation, this cooling effect is meaningfully larger than the cooling-cover gel-foam approach used by most competitors. The grid also relieves pressure at the shoulders and hips without the slow-response sink of memory foam, which matters for patients making multiple nocturia transitions -- the grid rebounds instantly so the patient does not have to fight the mattress to sit up. The coil base provides edge support for safe nocturia transitions and adjustable-base compatibility for head-of-bed elevation to manage non-dipping nocturnal BP. There is no VOC off-gassing from the polymer grid, which matters for patients on multiple chronic medications who want to minimize total chemical load. Motion isolation is good though not class-leading -- a partnered Conn's patient with very frequent nocturia might still prefer the Helix Midnight Luxe.
For Conn's syndrome patients on a budget -- and many are managing significant medical and pharmacy costs alongside diagnostic workup -- the Nectar Premier Copper delivers the essential features at a price well below premium options. The copper-infused gel foam provides genuine surface-temperature reduction, helpful for the night-sweats and restlessness that accompany metabolic alkalosis. The CertiPUR-US certification confirms VOC emissions are below safety thresholds -- important for medication-heavy patients minimizing total chemical exposure. The mattress is fully adjustable-base compatible for the 10-15 degree head elevation that addresses non-dipping nocturnal BP and morning headache. Motion isolation is strong (a property of all-foam construction), which matters for partnered patients with the 3-5 nightly nocturia trips characteristic of Conn's syndrome. The major trade-off versus pricier picks is pressure relief during hypokalemic cramp flares -- the Nectar provides adequate cushioning but does not match the Tempur-Pedic ProAdapt or Saatva Solaire for cramp-prone patients. Edge support is adequate but not exceptional, so patients with significant orthostatic hypotension on MRA therapy should consider pairing the mattress with a sturdy adjustable base that does not flex at the edges. The 365-night trial gives ample time to evaluate whether the Conn's-specific symptoms improve.
Patients on long-term mineralocorticoid receptor antagonist therapy -- spironolactone or eplerenone, often for life in bilateral adrenal hyperplasia -- benefit from minimizing total chronic chemical exposure from all sources, including the sleep environment. The Avocado Green eliminates polyurethane foam entirely; every layer is GOLS-certified organic latex, GOTS-certified organic cotton, or organic wool. There are no synthetic foam VOCs, no chemical fire retardants, and no petrochemical processing residues to contribute to cumulative chemical load. Natural latex is also inherently dust mite and microbial resistant, important for medication-immunomodulated patients. The medium-firm feel supports the back and hips during head-of-bed elevation for non-dipping nocturnal BP management. Natural latex has fast rebound -- unlike memory foam, the patient does not have to fight the mattress to sit up for nocturia trips, which is gentler on orthostatic-vulnerable MRA-treated patients. Coil support provides edge stability for safe transitions to standing. The mattress is fully adjustable-base compatible. The 365-night trial allows time to assess whether long-term symptom control improves on a fully organic sleep surface. This is the premium pick for the patient committed to long-term medical therapy who wants the lowest-chemical sleep environment available.
| Mattress | Best For | BP Elevation | Cramp Pressure Relief | Motion Isolation (Nocturia) | Cooling | Trial |
|---|---|---|---|---|---|---|
| Saatva Solaire | All-mechanism control | Built-in head + foot | Excellent (adjustable firmness) | Very good | Very good | 365 nights |
| Tempur-ProAdapt | Hypokalemic cramps | Compatible | Class-leading | Excellent | Good (cooling cover) | 90 nights |
| Helix Midnight Luxe | Partnered with nocturia | Compatible | Very good | Class-leading | Very good (Tencel) | 100 nights |
| Saatva Classic | Morning headache from BP | Compatible (smooth flex) | Good | Good | Good (coil airflow) | 365 nights |
| Purple Restore Hybrid | Metabolic alkalosis sweats | Compatible | Very good (grid) | Good | Class-leading | 100 nights |
| Nectar Premier Copper | Budget Conn's patient | Compatible | Adequate | Very good | Good (copper-infused) | 365 nights |
| Avocado Green | Long-term MRA therapy | Compatible | Good (latex bounce) | Good | Very good (latex airflow) | 365 nights |
| Your Situation | Best Pick | Why |
|---|---|---|
| All four mechanisms active, no budget cap | Saatva Solaire | Built-in elevation + adjustable firmness covers every Conn's dimension |
| Severe nocturnal hypokalemic cramps | Tempur-Pedic ProAdapt | Class-leading pressure relief eliminates cramp trigger points |
| 3-5 nocturia trips disturbing partner | Helix Midnight Luxe | Hotel-grade motion isolation + edge support for safe transitions |
| Early-morning BP-driven headache | Saatva Classic | Smooth-flex hybrid optimized for sustained head elevation |
| Night sweats from metabolic alkalosis | Purple Restore Hybrid | Polymer grid is the most thermally neutral comfort layer available |
| Diagnostic workup phase, budget tight | Nectar Premier Copper | CertiPUR-US + 365-night trial covers the essentials affordably |
| Lifelong spironolactone or eplerenone | Avocado Green | Zero petrochemical foam for minimum chronic chemical exposure |
Primary aldosteronism (Conn's syndrome) disrupts sleep through four distinct mechanisms. First, aldosterone excess drives resistant hypertension that often follows a non-dipping nocturnal pattern -- blood pressure fails to fall by the normal 10-20% overnight, increasing cardiovascular load during sleep and causing early-morning headaches. Second, renal potassium wasting causes hypokalemia, which produces nocturnal muscle cramps, weakness, and uncomfortable paresthesias that fragment sleep. Third, aldosterone-driven sodium and water retention causes polyuria with frequent nocturia -- often 3-5 nighttime bathroom trips. Fourth, metabolic alkalosis from hydrogen ion loss can cause subtle respiratory drive changes and restless sleep. A mattress for Conn's syndrome must address all four: adjustable-base elevation for BP and headache management, pressure-relief layers for cramp-prone muscles, strong motion isolation for partner-sparing during nocturia trips, and cooling materials for fragmented-sleep recovery.
Essential hypertension typically responds to 1-2 medications and shows normal nocturnal dipping. Primary aldosteronism (Conn's syndrome) is a secondary, surgically curable cause of hypertension characterized by autonomous aldosterone secretion -- usually from an aldosterone-producing adenoma (APA) or bilateral adrenal hyperplasia (BAH). It causes resistant hypertension (uncontrolled on three or more medications including a diuretic), often with hypokalemia and metabolic alkalosis. From a mattress selection standpoint, the key differences are: (1) Conn's patients frequently have non-dipping or reverse-dipping nocturnal BP, making head-of-bed elevation more important; (2) hypokalemia adds a muscle-cramp dimension absent in essential hypertension; (3) nocturia from aldosterone-driven polyuria is far more frequent and disruptive; (4) many patients are on mineralocorticoid receptor antagonists (spironolactone, eplerenone) which can cause gynecomastia tenderness in men and require side-sleeper pressure relief. A standard "hypertension mattress" approach underserves these patients.
Yes, in most cases. Head-of-bed elevation of 10-15 degrees has three benefits specific to primary aldosteronism. First, it modestly reduces nocturnal blood pressure by reducing venous return and preload, helping the resistant-hypertension non-dipping pattern characteristic of Conn's syndrome. Second, it reduces early-morning headache severity -- a common complaint driven by elevated overnight BP. Third, it can reduce nocturia frequency slightly by promoting peripheral fluid pooling during the day rather than nighttime mobilization. However, elevation is contraindicated or modified if the patient has orthostatic hypotension from spironolactone or eplerenone overdiuresis -- in that case, a flat-but-supportive surface is preferable, and the patient should sit on the bed edge for 30 seconds before standing. Always confirm with the treating endocrinologist or cardiologist before adopting any elevation protocol.
The aldosterone-to-renin ratio (ARR) is the screening test for primary aldosteronism. Sleep itself does not change the test, but several practical considerations apply. The blood draw is taken mid-morning after the patient has been upright for at least 2 hours -- this means sleep position the night before does not affect the result, but the patient should not draw the labs immediately on waking. Several medications interfere with ARR: mineralocorticoid receptor antagonists (spironolactone, eplerenone) must be stopped 4-6 weeks before testing, and many antihypertensives need adjustment. During this washout period, blood pressure may be poorly controlled and sleep symptoms (headache, restlessness, nocturia) may temporarily worsen -- a comfortable, elevation-capable mattress becomes more important during this window. After diagnosis is confirmed via confirmatory testing and adrenal imaging, patients pursue either adrenalectomy (for unilateral APA) or lifelong mineralocorticoid receptor antagonist therapy (for bilateral disease).
Mineralocorticoid receptor antagonist (MRA) therapy -- spironolactone or the more selective eplerenone -- is the medical treatment for bilateral adrenal hyperplasia and a temporary or permanent option for APA patients who decline or are unsuitable for adrenalectomy. MRAs change mattress needs in three ways. First, they often resolve hypokalemia and nocturia within weeks, but may cause orthostatic hypotension -- making the transition from lying to standing important. A medium-firm mattress with good edge support helps the patient sit up safely. Second, spironolactone (less so eplerenone) can cause gynecomastia in men and breast tenderness in women, making chest pressure during prone or side sleeping uncomfortable -- pressure-relieving comfort layers help. Third, MRAs can cause mild hyperkalemia in some patients, with associated paresthesias and restless leg-like sensations -- cooling, motion-isolating beds prevent these symptoms from waking a partner. The Saatva Solaire and Tempur-Pedic ProAdapt address all three concerns better than budget options.